Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ABA-101 by Abata Therapeutics for Primary Progressive Multiple Sclerosis (PPMS): Likelihood of Approval
ABA-101 is under clinical development by Abata Therapeutics and currently in Phase I for Primary Progressive Multiple Sclerosis (PPMS). According...